Variant position: 313 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 470 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human QELNLTGSFWNDSFARLSLT YE-RLFGTTVTFKFILANRLYP
Mouse ENLNLTGSFWNDSFAMLSLT YE-PLFGATVTFKFILASRFY
Rat ENLNLTGSFWNDSFAMLSLT YE-PLFGATVTFKFILASRFY
Bovine QDLNLTGSFWNDTVARLVLT YD-SLFGTMVTFKFILANSYY
Drosophila TDLKLT----NSSSTKLSVV MDTSVADKPITFDVVYNGGY-
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
42 – 470 V-type proton ATPase subunit S1
42 – 419 Vacuolar
296 – 296 N-linked (GlcNAc...) asparagine
303 – 303 N-linked (GlcNAc...) asparagine
304 – 316
ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation.
Jansen E.J.; Timal S.; Ryan M.; Ashikov A.; van Scherpenzeel M.; Graham L.A.; Mandel H.; Hoischen A.; Iancu T.C.; Raymond K.; Steenbergen G.; Gilissen C.; Huijben K.; van Bakel N.H.; Maeda Y.; Rodenburg R.J.; Adamowicz M.; Crushell E.; Koenen H.; Adams D.; Vodopiutz J.; Greber-Platzer S.; Mueller T.; Dueckers G.; Morava E.; Sykut-Cegielska J.; Martens G.J.; Wevers R.A.; Niehues T.; Huynen M.A.; Veltman J.A.; Stevens T.H.; Lefeber D.J.;
Nat. Commun. 7:11600-11600(2016)
Cited for: INVOLVEMENT IN IMD47; VARIANTS IMD47 PRO-144; CYS-313; LYS-346 AND ILE-428; CHARACTERIZATION OF VARIANTS IMD47 CYS-313; LYS-346 AND ILE-428; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; GLYCOSYLATION; MUTAGENESIS OF VAL-470;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.